Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post‐transcriptional level in HepG2 cells
Authors:
- 19 June 2004
- journal article
- Published by Wiley in FEBS Letters
- Vol. 570 (1-3) , 37-40
Abstract
Histone deacetylase inhibitors (HDIs) are thought to act primarily at the level of transcription inducing cell cycle arrest, differentiation and/or apoptosis in many cancer cell types. Induction of the potent cdk/cyclin inhibitor p21WAF1 is a key feature of this HDI mediated transcriptional re‐programming phenomenon. However, in the current study we report that HDIs are also capable of inducing p21WAF1 through purely post‐transcriptional events, namely increased mRNA stability. These studies highlight our growing appreciation for the complexities of HDI mediated effects and challenge our preconceptions regarding the action of these promising anti‐neoplastics.Keywords
This publication has 18 references indexed in Scilit:
- Histone Deacetylase Inhibitors: From Chromatin Remodeling to Experimental Cancer TherapeuticsCurrent Medicinal Chemistry, 2003
- Histone deacetylase inhibitors in cancer treatmentAnti-Cancer Drugs, 2002
- Activation of p21WAF1/Cip1 Transcription through Sp1 Sites by Histone Deacetylase Inhibitor ApicidinJournal of Biological Chemistry, 2001
- Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylationProceedings of the National Academy of Sciences, 2000
- Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed CellsJNCI: Journal of the National Cancer Institute, 2000
- Acetylation: a regulatory modification to rival phosphorylation?The EMBO Journal, 2000
- Therapeutic Targeting of Transcription in Acute Promyelocytic Leukemia by Use of an Inhibitor of Histone DeacetylaseJNCI: Journal of the National Cancer Institute, 1998
- p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cellsProceedings of the National Academy of Sciences, 1998
- Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell LineJournal of Biological Chemistry, 1997
- The effect of sodium butyrate on histone modificationCell, 1978